Community Collective: Time Well Spent – Navigating the Challenges of Treating Obesity and Diabetes is an educational curriculum designed for rural primary care clinicians to enhance outcomes for individuals with obesity through improved diagnosis and use of therapy options to treat type 2 diabetes (T2D). This regional series consists of three individual activities (2 virtual and 1 live in-person) tailored to the educational needs of rural U.S.-based clinicians who treat patients with T2D and obesity and practice in geographic areas with a greater prevalence of the disease. Local experts will share their experiences in the treatment of T2D and obesity and will also discuss disease-related risk factors and comorbidities, strategies to treating and managing T2D and obesity, the most recent safety and efficacy data for approved and emerging T2D medications, as well as approaches for shared decision-making and addressing health inequities within rural populations. Community Collective is designed to facilitate networking and collaborative consultation among local clinicians and practicing clinicians who practice in your area.
Speakers
Robert F. Kushner, MD
Professor, Departments of Medicine and Medical Education Northwestern University Feinberg School of Medicine
Chicago, IL
Robert Kushner, MD is Professor of Medicine and Medical Education at Northwestern University Feinberg School of Medicine, and Director of the Center for Lifestyle Medicine in Chicago, IL, USA. After finishing a residency in Internal Medicine at Northwestern University, he went on to complete a postgraduate fellowship in Clinical Nutrition and earned a Master’s degree in Clinical Nutrition and Nutritional Biology from the University of Chicago, IL, USA. Dr. Kushner is past President of The Obesity Society, the American Society for Parenteral and Enteral Nutrition, and the American Board of Physician Nutrition Specialists (ABPNS), and a founder and first Chair of the American Board of Obesity Medicine (ABOM). Dr. Kushner has authored over 250 original articles, reviews, books and book chapters covering medical nutrition, medical nutrition education and obesity, and is an internationally recognised expert on the care of patients with overweight or obesity issues. He is author/editor of multiple books; current books include Nutrition and Bariatric Surgery (CRC Press, 2015), Lifestyle Medicine: A Manual for Clinical Practice (Springer, 2016), Creating a Lifestyle Medicine Center (Springer, 2020), Six Factors to Fit – Weight Loss that Works for You! (Eat Right Press, 2020), and Primary Care: Evaluation and Management of Obesity (Wolters Kluwer, 2022).
Carlos Campos, MD, MPH, CDCES
Clinical Adjunct Professor
Dept. of Family Medicine
UT Health San Antonio
New Braunfels, TX
Dr. Carlos Campos was born and raised in New Braunfels, Texas. He received an Associates of Arts degree from Schriener University and a Bachelors degree from Baylor University followed by Medical School at Baylor College of Medicine. He has been Board Certified by the American Academy of Family Physicians since 1984.In addition, Dr. Campos also received a Master's of Public Health Degree from the University of Texas School of Public Health. In May 2012, he received his Certified Diabetes Educator status. In 2016, he became Board Certified in Obesity Medicine.He has been practicing as a primary care physician in New Braunfels since 1984. Dr. Campos was appointed by the Governor to the Texas Medical Board and served from 1993 to 1999. In 1993, he was also the Chief of Staff of the local New Braunfels hospital, McKenna Memorial Hospital. He also serves as a Clinical Adjunct Professor for the Department of Family Medicine at the UT Health Science Center at San Antonio.
In 2000, Dr. Campos established The Institute for Public Health and Education Research Inc. (TIPHER) a non-profit corporation. Dr. Campos now serves as Executive Director for TIPHER. TIPHER's mission statement is to: Improve the quality of life by addressing public health needs and critical education issues.
Dr. Campos was the founding Medical Director for Resolute Health Center For Wellbeing/Diabetic Center.
Dr. Campos has had multiple publications on diabetes and obesity related topics. He was previously on the Editorial Board for the journal of Clinical Diabetes.
Keisha Harvey-Mansfield, MD
Diplomate ABFM, Diplomate ABOM, Diplomate ACLM
Medical Director and Founder, Dr. K's Family Medicine
Bogalusa, LA
Keisha Harvey Mansfield is a family medicine physician, obesity medicine expert, diplomat of the American College of Lifestyle Medicine, and life coach. She is the founder of Dr. K's Family Medicine in Bogalusa, LA. Bogalusa is a rural area where 37% of individuals have obesity, 49.8% have hypertension, 54.4% have hyperlipidemia, 13% are diabetic, and 29% are smokers. Therefore, she devotes much of her time to educating patients on small lifestyle changes that can lead to longstanding results. Dr. K's Family Medicine is a 501(c)3 nonprofit that offers affordable, comprehensive healthcare despite an individual's ability to pay.
Dr. Harvey-Mansfield completed her medical education at Meharry Medical College. She completed her residency at the LSU Rural Family Medicine program in Bogalusa where she also received awards in compassion and leadership. Shortly after completing her residency, she was compelled to go into private practice because she wanted more autonomy and freedom to practice medicine in an impactful way.
Eden Miller, DO, Dip ABOM
Co-Founder
Diabetes and Obesity Care, LLC
Bend, OR
Dr. Eden Miller, an Osteopathic board-certified Family Practitioner, received her medical degree from Kirksville College of Osteopathic Medicine in 1997. Returning to the Northwest, she completed her residency in Family Practice at East Moreland Hospital in Portland, Oregon. Recently completing her certification in Obesity management, she is the founder of Diabetes Nation a nonprofit organization, and CEO of Diabetes and Obesity Care LLC where she practices with her husband Dr. Kevin Miller in Bend.
Dr. Miller has cultivated a special interest in diabetes, after contracting type-1 diabetes while in medical school. Out of that personal experience, her practice has extended into a subspecialty in diabetes care. An impassioned speaker, Dr. Miller has given over 1250 lectures in the field of Diabetes to health care providers and patients alike, on subjects such as Diabetes Management, CGM Technology, Insulin Pump Therapy, Obesity and Metabolism intervention, Clinical Research, and Healthcare Policy. Her adage for care is that she “only succeeds as a provider if she turns patients into experts on their own disease”.
Dr. Miller believes that a “physiologic patient individualized approach to diabetes intervention is crucial to success. She feels if our nation is to triumph over the ravages of diabetes, a collaborative effort; unhindered by fear of personal scrutiny, and barriers for effective treatment need to be removed”.
For her, Diabetes and Obesity Care provides the foundational model to impact the people that represent this disease and begin the process of restoring hope back to their lives.
Kevin Miller, DO
Physician
Diabetes and Obesity Care, LLC
Bend, OR
Dr. Kevin Miller, an Osteopathic board-certified Family Practitioner, received his medical degree from Kirksville College of Osteopathic Medicine in 1995. He accompanied his physician wife to the Pacific Northwest following, following completing his Residency training at Cuyahoga Fall General Hospital in Ohio. He is the co-founder of Diabetes Nation a non-profit organization, and co-founder of Diabetes and Obesity Care where he practices part-time with his wife Dr. Eden Miller in Bend, Oregon. Dr. Miller has cultivated a special interest in diabetes, health and exercise, and disease prevention.
An experienced clinician and leader, Dr. Miller’s involvement has included service to the state as a board member and president to Oregon’s Osteopathic medical association, Oregon’s rural health coordinating council member, a founding member of the Bryan Institute of Physician Leadership, and recently completed his fellowship in Health Care Policy. He currently serves on the American Diabetes Association Primary Care Committee.
Dr. Kevin Miller believes Diabetes and Obesity Care provides the foundational model to identify disease risk, improve health, reduce complications, and impact the financial burdens chronic medical conditions place on our world.
Accreditation and Disclosure Information
Target Audience
This activity is intended for physicians, physician associates, nurse practitioners, and nurses, involved in the care of patients with both T2D and obesity.
Educational Objectives
After completing this activity, the participant should be better able to:
- Use three evidence-based screening metrics beyond HbA1C (OGTT, GV, TIR) to assess whether to initiate or intensify T2D therapy, with consideration of obesity as a comorbidity.
- Determine the chronicity of obesity as a comorbidity and the importance of its timely management to mitigate risk of longterm complications in T2D.
- Select the most appropriate therapy for an individual patient with T2D and obesity with consideration of the latest safety and efficacy data of GLP-1 RAs and dual GIP/GLP-1 RAs and ADA/EASD Consensus Statements.
- Identify patient- and disease- appropriate goals for the long-term management of weight loss and T2D related complications utilizing shared decision-making approaches and patient-reported outcomes.
Program Agenda
Part 1, Reframing How We Approach T2D Management in Primary Care: Making Time to Address Obesity in Your Busy Practice
- Redefining treatment goals and targets in T2D Management
- Considering the dual management of T2D and obesity: a holistic approach
- Building a solid foundation for patient collaborating in newly diagnosed T2D
Part 2, Expanding the Role of GLP-1 Receptor Agonists and GIP/GLP-1 Dual Agonists in the Management of T2D and Obesity: Practical Applications for PCPs
- Latest safety and efficacy data for GLP-1 RAs and dual GIP/GLP-1 RAs in T2D and obesity
- Establishing trust with shared-decision making: approaches to T2D therapy intensification
- Putting it to practice: practical approaches in primary care
Accreditation, Support and Credit
In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
Physician Associate Credit Designation Statement
Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. Approval is valid until November 9, 2024. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 2.0 contact hours and 1.0 contact hour in the area of pharmacology.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Support Statement
This activity is supported by an educational grant from Lilly.
Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc., is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
Moderator/Host/Planner
Robert F. Kushner, MD
Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Chicago, IL
Robert F. Kushner, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Altimmune, Boehringer Ingelheim, Lilly, Novo Nordisk, Pfizer, Weight Watchers
Research Grant: Novo Nordisk
Planner/Presenter
Carlos Campos, MD, MPH, CDCES
Clinical Adjunct Professor
Department of Family Medicine
UT Health San Antonio
New Braunfels, TX
Carlos Campos, MD, MPH, CDCES, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Boehringer Ingelheim, Lilly, Novo Nordisk
Speakers’ Bureau: Boehringer Ingelheim, Lilly, Novo Nordisk
Planner/Presenter
Keisha Harvey-Mansfield, MD
Diplomate ABFM, Diplomate ABOM, Diplomate ACLM
Medical Director and Founder, Dr. K's Family Medicine
Bogalusa, LA
Keisha Harvey-Mansfield, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.
Planner/Presenter
Eden Miller, DO, Dip ABOM
Co-Founder, Diabetes and Obesity Care LLC
Bend, OR
Eden Miller, DO, Dip ABOM, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Abbott, Bayer, Eli Lilly/Boehringer Ingelheim, Insulet, Novo Nordisk
Research Grant: Abbott
Speakers’ Bureau: Abbott, Bayer, Eli Lilly/Boehringer Ingelheim, Novo Nordisk
Planner/Presenter
Kevin Miller, DO
Physician, Diabetes and Obesity Care LLC
Bend, OR
Kevin Miller, DO, has a financial interest/relationship or affiliation in the form of:
Research Grant: Abbott
Independent Contractor: Semler Insulin Insights
The following relationships have ended within the last 24 months:
Independent Contractor: Novo Nordisk
All of the relevant financial relationships of individuals for this activity have been mitigated.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. You will receive your certificate from Medical Learning Institute, Inc. If you have questions regarding your certificate, please contact mvu@mlieducation.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.
About This Activity
Medical Learning Institute, Inc. is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by an educational grant subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.
Copyright © 2023 Medical Learning Institute, Inc. All Rights Reserved.